{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:06:33Z","timestamp":1780549593523,"version":"3.54.1"},"reference-count":133,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["20252BAC240143"],"award-info":[{"award-number":["20252BAC240143"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["20242BAB20346"],"award-info":[{"award-number":["20242BAB20346"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","award":["202311127"],"award-info":[{"award-number":["202311127"]}],"id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Province Key Laboratory of Bioengineering Drugs","award":["2024SSY07061"],"award-info":[{"award-number":["2024SSY07061"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Cardiovascular diseases (CVDs) continue to pose a key challenge to public health because of their high prevalence, mortality, and disability rates, together with a trend toward younger age at onset. Chronic inflammation and disordered lipid metabolism are key pathological mechanisms underlying the development and progression of CVDs. Although numerous pharmacological agents have been developed to intervene in CVDs, current therapies are still limited by adverse effects, suboptimal efficacy, and insufficient anti-inflammatory properties. Consequently, effective drug-based strategies for the prevention and treatment of certain CVDs are still insufficient. Cluster of differentiation 36 (CD36), a class B scavenger receptor, mediates the recognition and uptake of long-chain fatty acids, oxidized low-density lipoprotein, and other ligands, and is present in diverse tissues and cell types. Accumulating evidence indicates that CD36 plays a critical role in lipid metabolism and inflammatory signalling pathways implicated in CVDs, suggesting that it represents a promising focus for treatment-oriented interventions. This review synthesizes current evidence on the multifaceted roles of CD36 in lipid metabolism dysregulation and inflammation-associated pathways in CVDs and evaluates its potential as a tractable target for disease prevention and management.<\/jats:p>","DOI":"10.3390\/antiox15060694","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:33:14Z","timestamp":1780479194000},"page":"694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cluster of Differentiation 36-Mediated Inflammation and Lipid Metabolism in Cardiovascular Diseases: From Mechanisms to Novel Therapies"],"prefix":"10.3390","volume":"15","author":[{"given":"Jiayin","family":"Song","sequence":"first","affiliation":[{"name":"The Queen Mary School, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnuo","family":"Han","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Bioengineering Drugs, The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Innovation, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jiangxi Province Key Laboratory of Bioengineering Drugs, The National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang 330031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, October 13). Available online: https:\/\/www.who.int\/health-topics\/cardiovascular-diseases\/#tab5tab_1."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cetin, E., and Raby, A.C. (2025). Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics. Cells, 14.","DOI":"10.3390\/cells14110770"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ecl.2022.02.005","article-title":"Assessment of Cardiovascular Disease Risk","volume":"51","author":"Goldsborough","year":"2022","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cardfail.2025.07.007","article-title":"HF STATS 2025: Heart Failure Epidemiology and Outcomes Statistics An Updated 2025 Report from the Heart Failure Society of America","volume":"32","author":"Fonarow","year":"2025","journal-title":"J. Card. Fail."},{"key":"ref_5","first-page":"893","article-title":"Interpretation of Annual Report on Cardiovascular Health and Diseases in China 2024","volume":"38","author":"Liu","year":"2025","journal-title":"Biomed. Environ. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/17474930211017807","article-title":"Treatment of post-stroke aphasia: A narrative review for stroke neurologists","volume":"16","author":"Vitti","year":"2021","journal-title":"Int. J. Stroke"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.14715\/cmb\/2024.70.9.21","article-title":"The role of metabolic disorders in the development of atherosclerosis","volume":"70","author":"Blagov","year":"2024","journal-title":"Cell Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s42255-024-01015-w","article-title":"Dysregulated cellular metabolism in atherosclerosis: Mediators and therapeutic opportunities","volume":"6","author":"Stroope","year":"2024","journal-title":"Nat. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11883-020-00891-3","article-title":"Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications","volume":"22","author":"Sterpetti","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: Pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","article-title":"Oxidative Stress, Inflammation, and Vascular Aging in Hypertension","volume":"70","author":"Guzik","year":"2017","journal-title":"Hypertension"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ihara, K., and Sasano, T. (2022). Role of Inflammation in the Pathogenesis of Atrial Fibrillation. Front Physiol., 13.","DOI":"10.3389\/fphys.2022.862164"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: A collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e71056","DOI":"10.1096\/fj.202502269R","article-title":"From Bench to Clinic: Advances in Anti-Inflammatory Therapies for Atherosclerotic Coronary Artery Disease","volume":"39","author":"Wang","year":"2025","journal-title":"FASEB J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-Function of CD36 and Importance of Fatty Acid Signal Transduction in Fat Metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.R082933","article-title":"Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization","volume":"59","author":"Glatz","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16977","DOI":"10.1074\/jbc.M116.740092","article-title":"Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen","volume":"291","author":"Yu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41419-021-03813-6","article-title":"CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys","volume":"12","author":"Hou","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rac, M. (2025). Human CD36: Gene Regulation, Protein Function, and Its Role in Atherosclerosis Pathogenesis. Genes, 16.","DOI":"10.3390\/genes16060705"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Momeni-Moghaddam, M.A., Asadikaram, G., Akbari, H., Abolhassani, M., Masoumi, M., Nadimy, Z., and Khaksari, M. (2019). CD36 gene polymorphism rs1761667 (G > A) is associated with hypertension and coronary artery disease in an Iranian population. BMC Cardiovasc. Disord., 19.","DOI":"10.1186\/s12872-019-1111-6"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8098173","DOI":"10.1155\/cdr\/8098173","article-title":"Impacts of CD36 Variants on Plasma Lipid Levels and the Risk of Early-Onset Coronary Artery Disease: A Systematic Review and Meta-Analysis","volume":"2025","author":"Luo","year":"2025","journal-title":"Cardiovasc. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1590\/1414-431X20143825","article-title":"Associations between CD36 gene polymorphisms and susceptibility to coronary artery heart disease","volume":"47","author":"Zhang","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1038\/s41588-025-02372-2","article-title":"An African ancestry-specific nonsense variant in CD36 is associated with a higher risk of dilated cardiomyopathy","volume":"57","author":"Huffman","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"144806","DOI":"10.1016\/j.gene.2020.144806","article-title":"Gender-specific associations of CD36 polymorphisms with the lipid profile and susceptibility to premature multi-vessel coronary artery heart disease in the Northern Han Chinese","volume":"753","author":"Du","year":"2020","journal-title":"Gene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/emm.2014.38","article-title":"CD36, a scavenger receptor implicated in atherosclerosis","volume":"46","author":"Park","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature Dendritic Cells Phagocytose Apoptotic Cells via \u03b1v\u03b25 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_28","first-page":"1442","article-title":"CD36 actions in the heart: Lipids, calcium, inflammation, repair and more?","volume":"1861","author":"Abumrad","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/s41467-020-18565-8","article-title":"CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis","volume":"11","author":"Hao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/ehf2.14423","article-title":"Ubiquitin-specific protease 11-mediated CD36 deubiquitination acts on C1q\/TNF-related protein 9 against atherosclerosis","volume":"10","author":"Zeng","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","article-title":"The role of CD36 in cardiovascular disease","volume":"118","author":"Shu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.celrep.2018.12.022","article-title":"DHHC4 and DHHC5 Facilitate Fatty Acid Uptake by Palmitoylating and Targeting CD36 to the Plasma Membrane","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.7150\/ijbs.109220","article-title":"APT1-derived depalmitoylation of CD36 alleviates diabetes-induced lipotoxicity in podocytes","volume":"21","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-025-61875-y","article-title":"Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100808","DOI":"10.1016\/j.medj.2025.100808","article-title":"Trends and sociodemographic patterns in hypertension prevalence and treatment in China","volume":"6","author":"Cao","year":"2025","journal-title":"Med"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"106004","DOI":"10.1016\/j.phrs.2021.106004","article-title":"Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-\u03b21 pathway: Therapeutic role of roflumilast","volume":"175","author":"Tao","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Zhang, Y., Shi, W., Lu, L., Wei, J., Wang, J., Zhang, H., Pu, Y., and Yin, L. (2024). Angiotensin II Induces Vascular Endothelial Dysfunction by Promoting Lipid Peroxidation-Mediated Ferroptosis via CD36. Biomolecules, 14.","DOI":"10.3390\/biom14111456"},{"key":"ref_39","first-page":"2890","article-title":"Effect of Scavenger Receptor CD36 Gene Defect on Ambulatory Blood Pressure Rhythm and Metabolic Parameters in Patients with High-normal Blood Pressure","volume":"23","author":"Zhang","year":"2020","journal-title":"Chin. Gen. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0895-7061(03)00567-3","article-title":"Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives","volume":"16","author":"Hoshide","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., and Chen, R. (2018). Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules, 8.","DOI":"10.3390\/biom8030080"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11883-020-00870-8","article-title":"CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications","volume":"22","author":"Tian","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_43","unstructured":"American Heart Association (2025, October 09). Available online: https:\/\/professional.heart.org."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI9259","article-title":"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice","volume":"105","author":"Febbraio","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.ATV.19.5.1333","article-title":"CD36, a Novel Receptor for Oxidized Low-Density Lipoproteins, Is Highly Expressed on Lipid-Laden Macrophages in Human Atherosclerotic Aorta","volume":"19","author":"Nakata","year":"1999","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Bezhaeva, T., Karper, J., Quax, P.H.A., and de Vries, M.R. (2022). The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.820962"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPAR\u03b3","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_53","first-page":"136","article-title":"CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima","volume":"119","author":"Park","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/db10-1353","article-title":"Hematopoietic Cell\u2013Restricted Deletion of CD36 Reduces High-Fat Diet\u2013Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue","volume":"60","author":"Nicholls","year":"2011","journal-title":"Diabetes"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.119.315833","article-title":"Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses","volume":"125","author":"Chen","year":"2019","journal-title":"Circ. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"101129","DOI":"10.1016\/j.xcrm.2023.101129","article-title":"Targeting phenylpyruvate restrains excessive NLRP3 inflammasome activation and pathological inflammation in diabetic wound healing","volume":"4","author":"Lv","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1626","article-title":"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype","volume":"13","author":"Podrez","year":"2007","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2011.04416.x","article-title":"Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein","volume":"9","author":"Lamers","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood-2016-11-750133","article-title":"Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/blood-2013-04-491688","article-title":"Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase\u2013signaling pathways","volume":"122","author":"Wraith","year":"2013","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: Chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: Looking beyond primary PCI","volume":"34","author":"Meier","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCHEARTFAILURE.112.000342","article-title":"Differential Translocation of the Fatty Acid Transporter, FAT\/CD36, and the Glucose Transporter, GLUT4, Coordinates Changes in Cardiac Substrate Metabolism During Ischemia and Reperfusion","volume":"6","author":"Heather","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"102878","DOI":"10.1016\/j.tice.2025.102878","article-title":"O-GlcNAc transferase-mediated O-GlcNAcylation of CD36 against myocardial ischemia-reperfusion injury","volume":"95","author":"Zhao","year":"2025","journal-title":"Tissue Cell."},{"key":"ref_66","first-page":"1461","article-title":"Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization","volume":"1861","author":"Glatz","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1096\/fj.201700450r","article-title":"Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair","volume":"32","author":"Dehn","year":"2018","journal-title":"FASEB J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/nrdp.2016.53","article-title":"Aortic dissection","volume":"2","author":"Nienaber","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1186\/s40001-025-03180-4","article-title":"Lower FT3 levels are associated with a poor prognosis in patients with acute type A aortic dissection: A retrospective study","volume":"30","author":"Tao","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41419-024-07022-9","article-title":"CD36-mediated ferroptosis destabilizes CD4+ T cell homeostasis in acute Stanford type-A aortic dissection","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1161\/CIRCRESAHA.125.326701","article-title":"Interplay Between Thrombospondin-1 and CD36 Modulates Platelet\u2013RBC Interaction in Thrombosis and Abdominal Aneurysm Formation","volume":"137","author":"Krott","year":"2025","journal-title":"Circ. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Infantes, D., Nus, M., Navas-Madro\u00f1al, M., Fit\u00e9, J., P\u00e9rez, B., Barros-Membrilla, A.J., Soto, B., Mart\u00ednez-Gonz\u00e1lez, J., Camacho, M., and Rodriguez, C. (2021). Oxidative Stress and Inflammatory Markers in Abdominal Aortic Aneurysm. Antioxidants, 10.","DOI":"10.3390\/antiox10040602"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrcardio.2010.180","article-title":"Pathophysiology and epidemiology of abdominal aortic aneurysms","volume":"8","author":"Nordon","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.33073\/pjm-2019-043","article-title":"Salmonella-Infected Aortic Aneurysm: Investigating Pathogenesis Using Salmonella Serotypes","volume":"68","author":"Chu","year":"2019","journal-title":"Pol. J. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.5650\/jos.ess18131","article-title":"Proprotein Convertase Subtilisin\/Kexin Type 9 Is Associated with Degenerating Adipocytes in Abdominal Aortic Aneurysm","volume":"67","author":"Tanaka","year":"2018","journal-title":"J. Oleo Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990\u20132017","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific Aortic Stenosis","volume":"60","author":"Dweck","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_79","first-page":"800","article-title":"Lipid Lowering on Progression of Mild to Moderate Aortic Stenosis: Meta-analysis of the Randomized Placebo-Controlled Clinical Trials on 2344 Patients","volume":"27","author":"Teo","year":"2011","journal-title":"Can. J. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1038\/s41467-022-33202-2","article-title":"Single-cell transcriptomics reveal cellular diversity of aortic valve and the immunomodulation by PPAR\u03b3 during hyperlipidemia","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.123.065213","article-title":"AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve Disease","volume":"149","author":"Han","year":"2024","journal-title":"Circulation"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.jacc.2018.09.063","article-title":"PCSK9 Involvement in Aortic Valve Calcification","volume":"72","author":"Poggio","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Cabodevilla","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: A comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_86","first-page":"E895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction","volume":"83","author":"Maddox","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"C283","DOI":"10.1093\/eurheartjsupp\/suad028","article-title":"Advanced heart failure: From definitions to therapeutic options","volume":"25","author":"Garascia","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00011.2023","article-title":"CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease","volume":"104","author":"Glatz","year":"2024","journal-title":"Physiol. Rev."},{"key":"ref_91","first-page":"1450","article-title":"The role of CD36 in the regulation of myocardial lipid metabolism","volume":"1861","author":"Kim","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1186\/s12967-025-06926-0","article-title":"CD36 attenuates pressure overload-induced myocardial insulin resistance via HSF1-dependent HSP90\u03b1 suppression and competitive disruption of the HSP90\u03b1-InsR complex","volume":"23","author":"Shu","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"H552","DOI":"10.1152\/ajpheart.00626.2016","article-title":"Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure","volume":"312","author":"Sung","year":"2017","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1038\/s41598-018-30616-1","article-title":"Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure","volume":"8","author":"Umbarawan","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"E618","DOI":"10.1152\/ajpendo.00106.2011","article-title":"Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice","volume":"301","author":"Steinbusch","year":"2011","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.7150\/ijms.107224","article-title":"CD36 knockdown attenuates pressure overload-induced cardiac injury by preventing lipotoxicity and improving myocardial energy metabolism","volume":"22","author":"Geng","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_97","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants. Lancet, 404, 2077\u20132093."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and Treatment of Diabetes in China, 2013\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"ref_99","first-page":"e45835","article-title":"Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways","volume":"15","author":"Zakir","year":"2023","journal-title":"Cureus"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13354","article-title":"T cells in obesity-associated inflammation: The devil is in the details","volume":"324","author":"Valentine","year":"2024","journal-title":"Immunol. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.114.303568","article-title":"Treating Atherosclerosis with Regulatory T Cells","volume":"35","author":"Foks","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cvr\/cvq360","article-title":"A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling","volume":"89","author":"Kennedy","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2337\/db19-0944","article-title":"Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in \u03b2-Cells","volume":"69","author":"Nagao","year":"2020","journal-title":"Diabetes"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.freeradbiomed.2019.02.004","article-title":"CD36 dependent redoxosomes promotes ceramide-mediated pancreatic \u03b2-cell failure via p66Shc activation","volume":"134","author":"Karunakaran","year":"2019","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.108.832915","article-title":"Increased Glucose Uptake and Oxidation in Mouse Hearts Prevent High Fatty Acid Oxidation but Cause Cardiac Dysfunction in Diet-Induced Obesity","volume":"119","author":"Yan","year":"2009","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"826","DOI":"10.14336\/AD.2020.1217","article-title":"CD36 Signaling in Diabetic Cardiomyopathy","volume":"12","author":"Zhang","year":"2021","journal-title":"Aging Dis."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Chen, M.Y., Meng, X.F., Han, Y.P., Yan, J.L., Xiao, C., and Qian, L.B. (2022). Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.983713"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI14006","article-title":"CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism","volume":"108","author":"Febbraio","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-020-2476-2","article-title":"Chemotherapy-induced pyroptosis is mediated by BAK\/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000464288","article-title":"Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice","volume":"54","author":"Yin","year":"2017","journal-title":"J. Vasc. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"109224","DOI":"10.1016\/j.biopha.2019.109224","article-title":"Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1","volume":"118","author":"Zhao","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"113677","DOI":"10.1016\/j.bcp.2019.113677","article-title":"Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats","volume":"170","author":"Santiago","year":"2019","journal-title":"Biochem Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPAR\u03b1 overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2004.07.015","article-title":"Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit","volume":"177","author":"Zhao","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1021\/acs.jafc.9b02647","article-title":"Protocatechuic Acid-Ameliorated Endothelial Oxidative Stress through Regulating Acetylation Level via CD36\/AMPK Pathway","volume":"67","author":"Han","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"155668","DOI":"10.1016\/j.phymed.2024.155668","article-title":"Baoyuan decoction inhibits atherosclerosis progression through suppression peroxidized fatty acid and Src\/MKK4\/JNK pathway-mediated CD 36 expression","volume":"130","author":"Wu","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11745-016-4178-1","article-title":"Danshensu Promotes Cholesterol Efflux in RAW264.7 Macrophages","volume":"51","author":"Gao","year":"2016","journal-title":"Lipids"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"115153","DOI":"10.1016\/j.biopha.2023.115153","article-title":"Sodium Danshensu stabilizes atherosclerotic vulnerable plaques by targeting IKK\u03b2 mediated inflammation in macrophages","volume":"165","author":"Zeng","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000530039","article-title":"High-Throughput CD36 Phenotyping on Human Platelets Based on Sandwich ELISA and Mutant Gene Analysis","volume":"51","author":"He","year":"2024","journal-title":"Transfus. Med. Hemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1021\/acsbiomaterials.9b01076","article-title":"Polymeric Vector-Mediated Targeted Delivery of Anti-PAK1 siRNA to Macrophages for Efficient Atherosclerosis Treatment","volume":"5","author":"Wu","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Mata-Cruz, C., Guerrero-Rodr\u00edguez, S.L., G\u00f3mez-Castellano, K., Carballo-Uicab, G., Almagro, J.C., P\u00e9rez-Tapia, S.M., and Velasco-Vel\u00e1zquez, M.A. (2025). Discovery and in vitro characterization of a human anti-CD36 scFv. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1531171"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00296-025-05894-4","article-title":"A novel approach to cardiovascular events in patients with systemic lupus erythematosus: Risk factor assessment and treatment analysis","volume":"45","author":"Suszek","year":"2025","journal-title":"Rheumatol. Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/09612033221147471","article-title":"Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis","volume":"32","author":"Bello","year":"2023","journal-title":"Lupus"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/acr.24988","article-title":"Causes of Death Among Individuals with Systemic Lupus Erythematosus by Race and Ethnicity: A Population-Based Study","volume":"75","author":"Taylor","year":"2023","journal-title":"Arthritis Care Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"oeab029","DOI":"10.1093\/ehjopen\/oeab029","article-title":"Inflammatory bowel disease and cardiovascular diseases: A concise review","volume":"2","author":"Wu","year":"2022","journal-title":"Eur. Heart J. Open"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.amjmed.2022.08.012","article-title":"Inflammatory Bowel Disease and Cardiovascular Diseases","volume":"135","author":"Chen","year":"2022","journal-title":"Am. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.gastrohep.2020.09.002","article-title":"La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular","volume":"44","author":"Mateo","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cellimm.2010.08.012","article-title":"Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients","volume":"266","author":"Yassin","year":"2010","journal-title":"Cell Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41419-024-06456-5","article-title":"Dietary long-chain fatty acids promote colitis by regulating palmitoylation of STAT3 through CD36-mediated endocytosis","volume":"15","author":"Wei","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/5245308","article-title":"Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis","volume":"2020","author":"Khatana","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/13813455.2013.808671","article-title":"Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease","volume":"119","author":"Wilhelmsen","year":"2013","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.3748\/wjg.v27.i40.6757","article-title":"Venous and arterial thromboembolism in patients with inflammatory bowel diseases","volume":"27","author":"Stadnicki","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/ejn.15147","article-title":"CD36\u2014A novel molecular target in the neurovascular unit","volume":"53","author":"Ioghen","year":"2021","journal-title":"Eur. J. Neurosci."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/6\/694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:39:37Z","timestamp":1780547977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/6\/694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":133,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["antiox15060694"],"URL":"https:\/\/doi.org\/10.3390\/antiox15060694","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}